Brainsway Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011007189
  • TAE: BWAY
ILS
40.00
-1.5 (-3.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

66.82 k

Shareholding (Jun 2023)

FII

0.00%

Held by 1 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

iScoreScore

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 18.12% and Operating profit at 36.76% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 1.21% signifying low profitability per unit of shareholders funds
2

With ROE of 12.12%, it has a Very Expensive valuation with a 7.05 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

ILS 1,669 Million ()

stock-summary
P/E

58.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.77

stock-summary
Return on Equity

12.62%

stock-summary
Price to Book

7.07

Revenue and Profits:
Net Sales:
51 Million
(Quarterly Results - Jun 2026)
Net Profit:
8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.05%
0%
-8.05%
6 Months
-4.76%
0%
-4.76%
1 Year
56.31%
0%
56.31%
2 Years
158.73%
0%
158.73%
3 Years
394.56%
0%
394.56%
4 Years
523.44%
0%
523.44%
5 Years
213.97%
0%
213.97%

Brainsway Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
18.12%
EBIT Growth (5y)
36.76%
EBIT to Interest (avg)
-9.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.11
Sales to Capital Employed (avg)
0.77
Tax Ratio
2.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
14.72%
ROE (avg)
1.21%

Valuation key factors

Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
7.05
EV to EBIT
80.18
EV to EBITDA
62.42
EV to Capital Employed
26.46
EV to Sales
8.07
PEG Ratio
0.62
Dividend Yield
NA
ROCE (Latest)
32.99%
ROE (Latest)
12.12%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 4.55% vs 2.33% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 12.68% vs -23.66% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.60",
          "val2": "48.40",
          "chgp": "4.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.40",
          "val2": "7.70",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "1.00",
          "chgp": "160.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.00",
          "val2": "7.10",
          "chgp": "12.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "139.80%",
          "val2": "129.10%",
          "chgp": "1.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.64% vs 29.52% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 141.67% vs 169.68% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "180.10",
          "val2": "151.80",
          "chgp": "18.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.20",
          "val2": "11.70",
          "chgp": "72.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "0.90",
          "chgp": "144.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.90",
          "val2": "4.10",
          "chgp": "117.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.10",
          "val2": "10.80",
          "chgp": "141.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.80%",
          "val2": "33.90%",
          "chgp": "4.89%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
50.60
48.40
4.55%
Operating Profit (PBDIT) excl Other Income
8.40
7.70
9.09%
Interest
2.60
1.00
160.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.00
7.10
12.68%
Operating Profit Margin (Excl OI)
139.80%
129.10%
1.07%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 4.55% vs 2.33% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 12.68% vs -23.66% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
180.10
151.80
18.64%
Operating Profit (PBDIT) excl Other Income
20.20
11.70
72.65%
Interest
2.20
0.90
144.44%
Exceptional Items
8.90
4.10
117.07%
Consolidate Net Profit
26.10
10.80
141.67%
Operating Profit Margin (Excl OI)
82.80%
33.90%
4.89%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 18.64% vs 29.52% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 141.67% vs 169.68% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Footer loading